FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950662079> ?p ?o ?g. }

• W2950662079 endingPage "180" @default.
• W2950662079 startingPage "171" @default.
• W2950662079 abstract "Management of venous thromboembolism (VTE) in patients with haematologic malignancies and thrombocytopenia is clinically challenging due to the related risks. No prospective studies or clinical trials have been carried out and, therefore, no solid evidence on this compelling issue is available.Given this, an expert panel endorsed by the Gruppo Italiano Malattie Ematologiche dell'Adulto Working Party on Thrombosis and Haemostasis was set up to produce a formal consensus, according to the RAND method, in order to issue clinical recommendations about the platelet (PLT) cut-off for safe administration of low molecular weight heparin (LMWH) in thrombocytopenic (PLT <100×109/L) adult patients with haematologic malignancies affected by acute (<1 month) or non-acute VTE.In acute VTE, the panel suggests safe anticoagulation with LMWH at therapeutic doses for PLT between ≥50<100×109/L and at 50% dose reduction for PLT ≥30<50×109/L. In acute VTE for PLT <30×109/L, the following interventions are recommended: positioning of an inferior vena cava (IVC) filter with prophylactic LMWH administration and platelet transfusion. In non-acute VTE, anticoagulation with LMWH at therapeutic doses for PLT between ≥50<100×109/L or over and at 50% dose reduction for PLT ≥30<50×109/L is considered appropriate. The discontinuation of full or reduced therapeutic dose of LMWH is recommended for PLT <30×109/L, both in acute and non-acute VTE.We suggest using dose-adjusted LMWH according to PLT to optimise anticoagulant treatment in patients at high bleeding risk." @default.
• W2950662079 created "2019-06-27" @default.
• W2950662079 creator A5006881585 @default.
• W2950662079 creator A5012674794 @default.
• W2950662079 creator A5031897642 @default.
• W2950662079 creator A5039120727 @default.
• W2950662079 creator A5039927165 @default.
• W2950662079 creator A5048449765 @default.
• W2950662079 creator A5052893667 @default.
• W2950662079 creator A5058124946 @default.
• W2950662079 creator A5059596200 @default.
• W2950662079 creator A5065997839 @default.
• W2950662079 creator A5085841362 @default.
• W2950662079 creator A5085901299 @default.
• W2950662079 creator A5087623314 @default.
• W2950662079 creator A5089351949 @default.
• W2950662079 date "2019-05-01" @default.
• W2950662079 modified "2023-10-18" @default.
• W2950662079 title "Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus." @default.
• W2950662079 cites W133525775 @default.
• W2950662079 cites W1494392238 @default.
• W2950662079 cites W1675801983 @default.
• W2950662079 cites W1969176274 @default.
• W2950662079 cites W1979903575 @default.
• W2950662079 cites W1984833612 @default.
• W2950662079 cites W2001715164 @default.
• W2950662079 cites W2003310408 @default.
• W2950662079 cites W2006318650 @default.
• W2950662079 cites W2010481138 @default.
• W2950662079 cites W2013564192 @default.
• W2950662079 cites W2013764507 @default.
• W2950662079 cites W2018856451 @default.
• W2950662079 cites W2023234945 @default.
• W2950662079 cites W2023807902 @default.
• W2950662079 cites W2030161884 @default.
• W2950662079 cites W2040026115 @default.
• W2950662079 cites W2041283702 @default.
• W2950662079 cites W2045391434 @default.
• W2950662079 cites W2046765669 @default.
• W2950662079 cites W2054324054 @default.
• W2950662079 cites W2073237059 @default.
• W2950662079 cites W2076827228 @default.
• W2950662079 cites W2077695446 @default.
• W2950662079 cites W2101131613 @default.
• W2950662079 cites W2115019673 @default.
• W2950662079 cites W2115107921 @default.
• W2950662079 cites W2116275499 @default.
• W2950662079 cites W2132100672 @default.
• W2950662079 cites W2138438886 @default.
• W2950662079 cites W2144182139 @default.
• W2950662079 cites W2149588262 @default.
• W2950662079 cites W2155682587 @default.
• W2950662079 cites W2156098321 @default.
• W2950662079 cites W2167494200 @default.
• W2950662079 cites W2169817261 @default.
• W2950662079 cites W2225937646 @default.
• W2950662079 cites W2313284959 @default.
• W2950662079 cites W2314836782 @default.
• W2950662079 cites W2316103399 @default.
• W2950662079 cites W246286872 @default.
• W2950662079 cites W2473697412 @default.
• W2950662079 cites W2491152492 @default.
• W2950662079 cites W2506615074 @default.
• W2950662079 cites W2529469085 @default.
• W2950662079 cites W2587774061 @default.
• W2950662079 cites W2607302953 @default.
• W2950662079 cites W2775434460 @default.
• W2950662079 cites W2789266226 @default.
• W2950662079 cites W2802130786 @default.
• W2950662079 cites W2810521167 @default.
• W2950662079 cites W2810860675 @default.
• W2950662079 cites W2989714602 @default.
• W2950662079 cites W4210997017 @default.
• W2950662079 cites W4247355438 @default.
• W2950662079 doi "https://doi.org/10.2450/2018.0143-18" @default.
• W2950662079 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6596377" @default.
• W2950662079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30418130" @default.
• W2950662079 hasPublicationYear "2019" @default.
• W2950662079 type Work @default.
• W2950662079 sameAs 2950662079 @default.
• W2950662079 citedByCount "17" @default.
• W2950662079 countsByYear W29506620792019 @default.
• W2950662079 countsByYear W29506620792020 @default.
• W2950662079 countsByYear W29506620792021 @default.
• W2950662079 countsByYear W29506620792022 @default.
• W2950662079 countsByYear W29506620792023 @default.
• W2950662079 crossrefType "journal-article" @default.
• W2950662079 hasAuthorship W2950662079A5006881585 @default.
• W2950662079 hasAuthorship W2950662079A5012674794 @default.
• W2950662079 hasAuthorship W2950662079A5031897642 @default.
• W2950662079 hasAuthorship W2950662079A5039120727 @default.
• W2950662079 hasAuthorship W2950662079A5039927165 @default.
• W2950662079 hasAuthorship W2950662079A5048449765 @default.
• W2950662079 hasAuthorship W2950662079A5052893667 @default.
• W2950662079 hasAuthorship W2950662079A5058124946 @default.
• W2950662079 hasAuthorship W2950662079A5059596200 @default.
• W2950662079 hasAuthorship W2950662079A5065997839 @default.
• W2950662079 hasAuthorship W2950662079A5085841362 @default.

• next